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chocardiographic Findings in
atients Meeting Task Force Criteria
or Arrhythmogenic Right Ventricular Dysplasia
ew Insights From the Multidisciplinary Study of Right Ventricular Dysplasia
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effery A. Towbin, MD,§ Wojciech Zareba, MD, PHD, Michael H. Picard, MD,* for the
ultidisciplinary Study of Right Ventricular Dysplasia Investigators
oston, Massachusetts; Tucson, Arizona; Baltimore, Maryland; Houston, Texas; and Rochester, New York
OBJECTIVES The purpose of this study was to quantify the echocardiographic abnormalities in probands
who were newly diagnosed with arrhythmogenic right ventricular dysplasia (ARVD).
BACKGROUND The diagnosis of ARVD remains challenging. The Multidisciplinary Study of Right
Ventricular Dysplasia was initiated to characterize the cardiac structural, clinical, and genetic
aspects of ARVD.
METHODS Detailed echocardiograms were performed in 29 probands and compared with echoes from 29
normal control patients matched for age, gender, body size, and year of echo. Right atrial
(RA) and right ventricular (RV) chamber dimensions, RV regional function, and the presence
of morphologic abnormalities (hyper-reflective moderator band, trabecular derangement, and
sacculations) were assessed. The RV systolic function was calculated as RV fractional area
change (FAC).
RESULTS The RV dimensions were significantly increased, and RV FAC was significantly decreased in
probands versus control patients (27.2  16 mm vs. 41.0  7.1 mm, p  0.0003).
The right ventricular outflow tract (RVOT) was the most commonly enlarged dimension in
ARVD probands (37.9  6.6 mm) versus control patients (26.2  4.9 mm, p  0.00001).
A RVOT long-axis diastolic dimension 30 mm occurred in 89% of probands and 14% of
controls. The RV morphologic abnormalities were present in many probands (trabecular
derangement in 54%, hyper-reflective moderator band in 34% and sacculations in 17%) but
not in controls.
CONCLUSIONS Probands with ARVD have significant RA and RV enlargement and decreased RV function,
which can be easily assessed on standard echocardiographic imaging. These parameters
should be measured when ARVD is suspected and compared with normal values. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.10.070Coll Cardiol 2005;45:860–5) © 2005 by the American College of Cardiology Foundation
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ardiomyopathy characterized by fibrofatty infiltration of
he right ventricular (RV) wall, which often leads to
entricular arrhythmias, RV dilation, and dysfunction, and
See page 866
ltimately may lead to RV failure (1,2). This condition
ften appears in young adulthood, appears to be more
ommon in men, and affected individuals may be asymp-
omatic or minimally symptomatic. Arrhythmia or sudden
ardiac death is often the first presentation of the condition
From the *Cardiac Ultrasound Laboratory, Massachusetts General Hospital,
arvard Medical School, Boston, Massachusetts; †University of Arizona, Tucson,
rizona; ‡Johns Hopkins University, Baltimore, Maryland; §Baylor College of
edicine, Houston, Texas; and University of Rochester, Rochester, New York. The
ultidisciplinary Study of Right Ventricular Dysplasia is supported by grant
L65549 from the National Heart, Lung, and Blood Institute of the National
nstitutes of Health, Bethesda, Maryland.t
Manuscript received August 3, 2004; revised manuscript received October 12,
004, accepted October 18, 2004.3). Arrhythmogenic right ventricular dysplasia has been
mplicated as a cause of sudden death in a significant
roportion of young athletes. The disease appears to be
nherited in an autosomal-dominant manner, thus making
creening of first-degree relatives important (4).
In 1994, the Task Force of the Working Group on
ardiomyopathies proposed a set of major and minor
riteria involving histologic, gross structural, and electrocar-
iographic (ECG) parameters to make the diagnosis of
RVD (5). Several major and minor criteria are evaluated
sing noninvasive testing and, when necessary, invasive
esting (Table 1). Some form of cardiac imaging is coupled
ith clinical signs and symptoms, family history, and results
f ECG and/or Holter monitoring to make the diagnosis.
Two-dimensional echocardiography, by virtue of its
idespread availability, low cost, and ease of performance
nd interpretation, has been one of the tools for establishing
he diagnosis of ARVD. Although several echocardio-
raphic findings have been associated with ARVD, many of
hese studies involved a small number of definite cases of
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March 15, 2005:860–5 Echocardiography in ARVDRVD (6) and were undertaken before the Task Force
riteria were written, thereby causing concern regarding
onuniformity of the study populations (7,8). Although the
oal of the Task Force Criteria was to improve the clini-
ian’s ability to make the diagnosis of ARVD, the criteria
or echocardiographic abnormalities are subjective and qual-
tative. The lack of standardized or quantifiable echocardio-
raphic criteria for ARVD has made the confirmation of
his diagnosis challenging. In addition, recent developments
Abbreviations and Acronyms
ARVD  arrhythmogenic right ventricular dysplasia
FAC  fractional area change
MRI  magnetic resonance imaging
RA  right atrial
RV  right ventricular
RVOT  right ventricular outflow tract
WMAs  wall motion abnormalities
able 1. Criteria for Diagnosis of Right Ventricular Dysplasia (5)
. Global and/or regional dysfunction and structural alterations*
Major
Severe dilatation and reduction of right ventricular ejection fraction
with no (or only mild) left ventricular impairment
Localized right ventricular aneurysms (akinetic or dyskinetic areas
with diastolic bulging)
Severe segmental dilatation of the right ventricle
Minor
Mild global right ventricular dilatation and/or ejection fraction
reduction with normal left ventricle
Mild segmental dilatation of the right ventricle
Regional right ventricular hypokinesia
I. Tissue characterization of wall
Major
Fibrofatty replacement of myocardium on endomyocardial biopsy
II. Repolarization abnormalities
Minor
Inverted T waves in right precordial leads (V2 and V3) in people
age 12 yrs, in absence of right bundle branch block
V. Depolarization/conduction abnormalities
Major
Epsilon waves or localized prolongation (110 ms) of the QRS
complex in right precordial leads (V1–V3)
Minor
Late potentials (signal-averaged ECG)
. Arrhythmias
Minor
Left bundle branch block type ventricular tachycardia (sustained
and nonsustained) by ECG, Holter, or exercise testing
Frequent ventricular extrasystoles (1,000/24 h) (Holter)
I. Family history
Major
Familial disease confirmed at necropsy or surgery
Minor
Family history of premature sudden death (35 yrs) due to
suspected right ventricular dysplasia
Familial history (clinical diagnosis based on present criteria)
rrhythmogenic right ventricular dysplasia diagnosis: two major criteria or one major
nd two minor criteria, or four minor criteria. *Detected by echocardiography,m
ngiography, magnetic resonance imaging, or radionuclide scintigraphy.
ECG  electrocardiogram.n instrumentation have lead to improvement in RV imag-
ng using cardiac ultrasonography.
In 2002, the Multidisciplinary Study of Right Ventricular
ysplasia was initiated to better characterize and quantify
he cardiac structural, clinical, and genetic aspects of ARVD
9). Detailed echocardiography has been performed in
ndividuals meeting Task Force Criteria and, thus, these can
e used to better define the echocardiographic abnormalities
ssociated with ARVD.
ETHODS
wenty-two centers have participated in this ongoing study,
nd 11 centers have enrolled patients with ARVD. In brief,
ndividuals with ventricular arrhythmias of left bundle
ranch block morphology and that have other major or
inor Task Force Criteria (Table 1) undergo two-
imensional echocardiography according to a detailed pro-
ocol. This protocol is the standard imaging protocol from
he Massachusetts General Hospital, with additional special
mphasis on adequate visualization of the RV.
At a core laboratory, the echocardiograms from the partic-
pating patients were analyzed by an individual who was
linded to the clinical and other diagnostic information
D.M.Y.). The presence of RV morphologic abnormalities
eported in ARVD, such as moderator band hyper-reflectivity,
rabecular derangement, focal RV sacculations, and aneurysms,
ere recorded (Fig. 1) (8). Measurements of cardiac structure
nd function included end-diastolic and end-systolic right
entricular inflow tract dimensions and right ventricular out-
ow tract (RVOT) dimensions in long- and short-axis views,
V long-axis dimensions, RV medial lateral dimensions, and
V area from the apical transducer position (Fig. 1) (10).
ight ventricular systolic function was calculated as RV frac-
ional area change (FAC) from the apical four-chamber view.
wo standard deviations greater than the published mean
alues for dimensions (10) and two standard deviations less
han the published mean value for FAC (11) were used to
iscriminate normal from abnormal values. Given a reference
alue of 46.5  7.1% for FAC (11), an RV FAC 26% and
32% was defined as mildly impaired and an FAC26% was
everely impaired. Right ventricular diastolic filling was as-
essed from peak tricuspid valve E and A velocities and
ricuspid valve E-wave deceleration time. The segments of the
V myocardium were identified using anatomic criteria iden-
ical to those used in the angiographic analysis in this study
RVOT, anterior, anteroseptal, apical, septal, inferobasal, in-
eroapical) and assessed for mild hypokinesis, severe hypoki-
esis, akinesis and dyskinesis, thinning, and diastolic bulging.
eft ventricular volume was measured by the single-plane
impson’s method, and ejection fraction was calculated from
he volumes. The RV systolic pressure was estimated from the
eak tricuspid regurgitant velocity on continuous wave Dopp-
er using the modified Bernoulli equation and assuming an RA
ressure of 10 mm Hg (12). The degrees of tricuspid and
itral regurgitation were assessed on color Doppler as none,
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Echocardiography in ARVD March 15, 2005:860–5race, mild, moderate, and severe (13). The RA and left atrial
olumes were calculated from linear dimensions by the ellip-
oid method (14).
Echocardiograms matched for age, gender, body size, and
ear performed were selected from the Massachusetts General
ospital echocardiographic archive of normal studies. The
rotocol for image acquisition in the control population was
imilar to that used by the enrolling centers. Identical mea-
urements were performed on these matched controls in a
linded fashion.
tatistical analysis. Data are presented as the mean  one
tandard deviation. Data were tested for normality using the
igure 1. Echocardiographic views from probands meeting Task Forc
entricular outflow tract (RVOT) enlargement from the parasternal long
pical four-chamber view showing a focal RV apical aneurysm (arrows),
E) apical four-chamber view showing a hyperreflective moderator ban
right atrium.hapiro-Wilk test for normality. Because all continuous Cariables were distributed normally, comparisons between
he ARVD probands and controls were performed with
aired t tests (Intercooled STATA 7, Chicago, Illinois).
hamber enlargement was defined as greater than two
tandard deviations outside of published mean values from
eference populations (10,11). Significance levels were ad-
usted for multiple comparisons using the Bonferroni cor-
ection and, therefore, p 0.003 was considered significant.
ESULTS
chocardiograms from 29 subjects who met the Task Force
iteria for arrhythmogenic right ventricular (RV) dysplasia. (A) Right
view, (B) RVOT enlargement from the parasternal short axis view, (C)
pical four-chamber view showing excessive trabeculations (arrows), and
ow). AoV  aortic valve; LA  left atrium; LV  left ventricle; RAe Cr
axis
(D) a
d (arrriteria for ARVD and were enrolled in this study as
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March 15, 2005:860–5 Echocardiography in ARVDrobands were analyzed. The baseline characteristics of
hese probands and the matched controls are listed in Table
. The age ranged from 15 to 58 years. No significant
ifferences in these characteristics were noted between the
roups. In 28 of these 29 probands, the diagnosis of ARVD
as made using Task Force Criteria exclusive of the
chocardiographic components. All probands and control
atients had normal left ventricular structure and systolic
unction.
V morphologic abnormalities. At least one RV morpho-
ogic abnormality occurred in 62% of probands, whereas two
r more RV morphologic abnormalities were present in 38%
f probands (Table 3). The most frequent morphologic
bnormality was trabecular derangement, occurring in 54%,
hereas hyper-reflective moderator band was present in
4% and sacculations were present in 17% of probands.
here were no RV morphologic abnormalities present in
ny control subject.
ight heart dimensions. The mean dimensions for the
A and RV are shown in Table 4. The systolic and diastolic
VOT and RV inflow tract dimensions were significantly
ncreased in probands versus controls. In comparison with
he published reference population data, the RVOT in
iastole, whether measured on its long axis or short axis, was
he most commonly enlarged dimension in these 29 affected
ndividuals (Fig. 1). An RVOT diameter of 25 mm (2
tandard deviations than the mean value from the reference
able 3. Frequency of Qualitative Echocardiographic
bnormalities in Probands With Arrhythmogenic Right
entricular Dysplasia (n  29)
Number Percent
V global function
Normal 11 38
Mildly reduced 8 28
Severely reduced 10 34
V regional WMA 23 79
RVOT 13 45
Anteroseptal 16 55
Anterior 20 70
Apex 21 72
Septal 16 55
Inferior basal 17 59
Inferior apical 15 52
yperreflective moderator band 9 31
xcessive/abnormal trabeculations 15 54
acculations 5 17
able 2. Baseline Characteristics
Probands Matched Controls p Value
umber 29 29
ge 37.0  14.2 37.1  14.2 NS
female ratio 12/29 12/29 NS
eight 67.8  4.1 67.4  4.0 NS
eight 157  28.5 157  27.4 NS
SA 1.83  0.2 1.83  0.2 NS
SA  body surface area; NS  not significant.R
V  right ventricular; RVOT  right ventricular outflow tract; WMA  wall
otion abnormality.opulation) was present in 100% of probands. We examined
eceiver-operator characteristics to determine sensitivity and
pecificity of the RVOT dimension, comparing probands
ith our control population. An RVOT long-axis dimen-
ion of 30 mm had the highest sensitivity and specificity
or the diagnosis of ARVD (89% and 86%, respectively).
he diastolic dimensions of the RV taken from the apical
our-chamber view were least commonly enlarged.
V function. Subjectively, the global RV function was
bnormal in 62% of probands (Table 3). Using the quanti-
ative criteria, global RV function was impaired in 66% of
he 29 probands (Table 5). Regional wall motion abnormal-
ties (WMAs) were present in 79% of probands. The apex
72%) and the anterior wall (70%) were the most common
ites of regional WMAs.
Normal global RV function (by quantitative assessment)
as present in 35% of the probands. Six of these 10 patients
60%) with a normal RV FAC had either focal regional
MAs and/or a morphological abnormality. In only one of
hese probands did a morphologic abnormality occur in the
bsence of WMAs. A mild reduction in RV function, as
epresented by a FAC between 32% and 25%, was present
n 24% of the total population. In these seven probands with
ildly impaired RV function, there were morphologic
bnormalities in 57% and focal regional WMA in 86%.
ISCUSSION
rrhythmogenic right ventricular dysplasia is a significant
ause of ventricular arrhythmias in the young. Its diagnosis
s challenging because most patients are asymptomatic, and
udden death is often the first manifestation of the disease.
critical component of the screening for and diagnosis of
his disease is noninvasive imaging of the right ventricle.
lthough there are echocardiographic criteria identified by
he ARVD Task Force to support the diagnosis of ARVD,
hese criteria are subjective. In addition, although echocar-
iography commonly is used when ARVD is suspected,
ontroversy exists regarding the relative importance of
arious morphologic findings for this diagnosis. In this
tudy, we carefully characterized, using echocardiography,
9 patients who met Task Force Criteria for ARVD. These
choes were performed at enrolling centers by sonographers
ho were trained to use the standard imaging protocol, with
pecial emphasis placed on complete visualization of the
V. Using quantitative techniques, none of these probands
ad a normal echocardiogram.
We found that RVOT dilation was the most common
bnormality associated with the Task Force Criteria diag-
osis of ARVD. An enlargement of the RVOT as defined
n the literature was present in 100%, and an RVOT
imension 30 mm was present in 89% of probands. Ad-
itionally, global RV dysfunction was present in more than
wo thirds of our population. When those with segmental
V dysfunction with a normal RV FAC are added to those
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Echocardiography in ARVD March 15, 2005:860–5ith global RV impairment, the presence of any RV dysfunc-
ion was noted in 82%. Thus, there is a strong association in
his population between diagnosis using ARVD Task Force
riteria and RV enlargement and dysfunction on echocardi-
graphy.
From our study, specific recommendations can be made
hat RV enlargement on echocardiography for the diagnosis
f ARVD should be defined as a diastolic RVOT dimension
rom the long axis view of 30 mm. Likewise, the use of
V dysfunction on echocardiography as the basis for diag-
osing ARVD can be defined as a FAC of 32% or the
resence of segmental RV WMAs. Enlargement of the
VOT should be the primary echocardiographic parameter
uantified when this disease is suspected.
Another observation from our data is the regional nature
f RV enlargement. In particular, we found that when
ssessing RV size from the apical four-chamber view, RV
nlargement frequently was not observed. It is common for
V dimensions to be assessed from the apical four-chamber
iew; however, our data suggest that when screening for
RVD, it is important to assess the RVOT dimension,
hich can easily be obtained from the parasternal long-axis
iew.
The need to combine global and regional RV function
ssessment in this diagnosis may represent one of the
hallenges of this disorder, namely a varying natural history.
able 4. Quantitative Echocardiographic Abnormalities
Right Heart Dimensions
ARVD Probands
(mm  SD)
A medial-lateral (mm) 44.8  11.4
A superior-inferior (mm) 51.3  10.6
VOT-PLAX diastole (mm) 37.9  6.6
VOT-PLAX systole (mm) 32.8  7.2
VOT-PSAX diastole (mm) 38.9  4.7
VOT-PSAX systole (mm) 28.3  6.1
VOT/aortic valve 1.28  0.2
VIT PLAX diastole (mm) 57.0  12.2
VIT PLAX systole (mm) 46.5  12.6
VIT PSAX diastole (mm) 37.3  8.5
VIT PSAX systole (mm) 32.3  8.5
V medial-lateral-apical 4-chamber diastole (mm) 34.0  8.9
V medial-lateral-apical 4-chamber systole (mm) 27.26  9.8
V LAX length-apical 4-chamber diastole (mm) 79.2  15.6
V LAX length-apical 4-chamber systole (mm) 66.7  15.8
p  0.003.
ARVD  arrhythmogenic right ventricular dysplasia; LAX  long-axis; PLAX
entricular; RVIT  right ventricular inflow tract; RVOT  right ventricular outflo
able 5. RV function
ARVD Prob
(Mean 
V end-diastolic area (cm2) 25.2  7
V end-systolic area (cm2) 18.9  8
V FAC (%) 27.2  1
ercent with FAC 32% 35%
ercent with FAC 26% to 32% (mildly impaired) 24%
ercent with FAC 26% (severely impaired) 41%p  0.003.
FAC  fractional area change; other abbreviations as in Table 4.lthough all of our probands were enrolled as newly
iagnosed with ARVD, these probands could have mani-
ested signs and/or symptoms of ARVD at varying time
oints in the disease process. It is possible that those with
ormal global RV function or only mildly impaired global
unction are at an earlier time course in the disease process.
y adding in the presence of regional wall motion and/or
orphologic findings that may occur in the early phase of
he disease, the strength of the echo as a diagnostic tool is
nhanced. However, most importantly, regardless of where
hese probands fall on the natural history spectrum of
RVD, all had RVOT enlargement.
There are a limited number of reports using echocardi-
graphy to aid in the diagnosis of ARVD, with most
erformed before the diagnostic criteria were defined by the
ask Force and before the widespread introduction of
armonic imaging, which improves RV visualization. Sev-
ral small series demonstrated abnormal RV size and func-
ion in patients with suspected ARVD (defined with clinical
nd angiographic criteria) compared with groups without
RVD (6,7,15). These studies found that the presence of
V dysfunction by two-dimensional echocardiography had
igh specificity and predictive value for ARVD (6); how-
ver, a clear set of echocardiographic diagnostic criteria have
ot been decided. Scognamiglio et al. (8) reported echocar-
iographic findings in asymptomatic individuals who were
atched Controls
(mm  SD) p Value
Reference Values
(10,11) (mm)
% of Probands
Enlarged
36.6  6.9 0.0035 37  4 41%
45.7  5.8 0.023 42  4 45%
26.2  4.9 0.00001 22  1.5 100%
20.1  4.0* 0.00001 NA
31.1  4.7* 0.00001 27  1 96%
19.0  5.1* 0.00001 NA
1.04  0.2* 0.0001 N/A
49.2  8.8 0.0065 45  2.5 73%
34.2  6.8* 0.0001 NA
28.1  5.2* 0.0004 30  1.5 60%
21.6  5.6* 0.0004 NA
25.1  4.0* 0.00001 30  5 18%
17.6  3.9* 0.00001 24  3 36%
76.1  7.6 0.2281 71  8 24%
61.2  6.0 0.0802 55  8 38%
asternal long-axis; PSAX  parasternal short-axis; RA  right atrial; RV  right
t.
Matched Controls
(Mean  SD) p Value
Reference
Value (11)
17.9  3.5* 0.00001 19.5  4.3
10.5  2.3* 0.00001 10.5  3.0
41.0  7.1* 0.0003 46.5  7.1
97%
3%
0%Mands
SD)
.7
.4
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March 15, 2005:860–5 Echocardiography in ARVDamily members of patients with ARVD. They described
everal features suggestive of ARVD, including an infero-
asal localized diastolic bulge, an abnormal trabecular pat-
ern, a highly reflective and irregularly shaped moderator
and, or an isolated dilatation of the RVOT. However,
one of these findings occurred frequently in their popula-
ion and, again, this study was performed in the pre-Task
orce era, which raises the question of diagnostic uncer-
ainty in the population studied. In our well-defined group,
hese echo features were very common. For example, tra-
ecular derangement occurred in 54% of our population
ersus 17% of their population. Lindstrom et al. (16) used
he new quantitative Doppler tool of tricuspid annular
otion to assess RV function. Although this is a promising
echnique to assess the RV, these parameters have been
ound to vary with age, and the normal range is still being
efined.
Similar findings have been noted with magnetic reso-
ance imaging (MRI). Tandri et al. (17) have found in a
ell-defined population of ARVD that trabecular disarray is
he most common morphologic abnormality and that RV
nlargement is common. Of note, an important value of the
ssessment via MRI was the ability to detect intramyocar-
ial fibrofatty infiltration.
tudy limitations. Several limitations can be raised from
ur study. Because RV enlargement can occur in a variety of
onditions, including congenital heart disease and pulmo-
ary hypertension, these conditions need to be excluded in
atients suspected to have ARVD. These conditions are
asily identifiable using standard echocardiography and
ere not found in any of our study subjects. Additionally,
bservations are based on what might appear to be a small
umber of probands. However, this is a rare disease,
ffecting approximately 1 in 5,000 (18), and our cases were
ollected from centers with specialized interest and expertise
n ARVD during the course of a long period. In fact, to our
nowledge, this population is larger than any of the previ-
usly published echocardiographic series of individuals
eeting Task Force Criteria for the diagnosis of ARVD. As
oted previously, another issue that confounds the interpre-
ation of our findings is that various probands are at different
ime points in their natural history of the disease. A previous
RI study has shown that the duration of symptoms
orrelates with the extent of RV enlargement (17). Finally,
ecause this trial is in progress, we are unable to correlate
ur findings with data from the other core laboratories and
hus are unable to determine the strength of association of
V enlargement and dysfunction on echocardiography with
V biopsy, MRI, arrhythmia, and angiography.
onclusions. In summary, echocardiography is a relatively
ensitive tool for identifying structural and functional ab-
ormalities when ARVD is suspected. In particular, the
ccuracy of the Task Force Criteria may be improved if
VOT enlargement and RV dysfunction are quantified. 1eprint requests and correspondence to: Dr. Danita M. Yo-
rger, Cardiac Ultrasound Laboratory, Massachusetts General
ospital, YAW 5, 55 Fruit Street, Boston, Massachusetts 02114.
-mail: dyoerger@partners.org.
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PPENDIX
or a list of the enrolling physicians, please see the March
5, 2005, issue of JACC at www.onlinejacc.org.
